I am fear when i know i am affected with blood cancer on 1st stage. Someone suggest me to take cytarabine injection. But i am confuse. I want to know is it helpful?
Or have any other way to cure blood cancer?
What is the best way to treat blood cancer?
Details:
Responses (2)
Revolutionary new treatment for myeloma
A Leukaemia & Lymphoma Research clinical trial saw the first patient in the world receive a new form of radiotherapy for myeloma. The new treatment delivers radioactive isoptopes directly to myeloma cells in the bone marrow without damaging healthy organs – a common side effect of conventional radiotherapy.
World first gene therapy trial for leukaemia
Our researchers developed a life saving treatment which is offering new hope to patients with acute myeloid leukaemia (AML) who cannot be cured with conventional chemotherapy. This innovative new treatment uses artificially activated anti-tumour cells, found naturally in the immune system, to destroy cancer cells. Joanne Scott, the first patient to be treated on this Leukaemia & Lymphoma Research clinical trial is still in remission.
Groundbreaking lymphoma trial avoids aggressive radiotherapy
Early results from a recent Leukaemia & Lymphoma Research clinical trial have shown that 70% of patients with Hodgkin lymphoma can have their treatment significantly reduced. This important study used PET scans, which measure response to chemotherapy, to guide treatment for each patient. Those who responded well to chemotherapy were spared radiotherapy, which has potentially damaging long term side effects.
Relieving the debilitating symptoms of myeloma bone disease
Our researchers have developed drugs that help prevent and repair bone pain caused by myeloma. This research, which is the first of its kind in the world, has had a major impact on the lives of many patients with myeloma, as before there were few treatments available.
Better treatment for chronic lymphocytic leukaemia
An important Leukaemia & Lymphoma Research clinical trial, called CLL4, confirmed the superiority of a new drug called fludarabine over conventional treatment with chlorambucil. Fludarabine is now used, along with another drug called cyclophospamide, as standard treatment for patients with chronic lymphocytic leukaemia (CLL).
Thanks for share useful information.
------
allchemiststore.com
Cytarabine Injection is best and cost effective solution for cure blood cancer
yes lisa. cytarabine is very effective medication to treat blood cancer.
When we fight cancer, we want to target tumors aggressively and spare surrounding healthy tissue. But blood cancers present unique challenges. Fewer treatments can truly pinpoint the cancerous cells that flow in a person’s bloodstream.
The answer may not be a new drug or therapy — but perhaps just a new way of using the drugs we have. New research shows that existing drugs used to fight blood-based cancers, such as leukemia, might work more effectively by adjusting treatment regimens. How much drug is administered and how often can be a game changer in cancer treatment.
New study explores blood cancer treatment
In a new study, researchers explored ways to treat life-threatening blood cancers in a less toxic way. They worked to wipe out cancer cells in the blood without destroying healthy surrounding cells. Yogen Saunthararajah, MD, who treats cancer patients at Cleveland Clinic, led the study. He explains how the new approach works by comparing it to a popular arcade game.
“The way the medicine works is like the game Whac-a-Mole™. You have a mallet and you’re only getting the moles that happen to be in a particular phase of their growth cycle. You don’t want a huge mallet because you’re just going to damage the golf green. You want a little mallet and you want to keep on whacking regularly,” Dr. Saunthararajah says.
In the same way, the new treatment involves using an existing drug but in a more targeted, repetitive way. The idea is to use more and smaller doses, as though the drug were the mallet you use to strike the cancer cells.
Sparing normal cells
Dr. Saunthararajah and his team focused the study on treating a blood cancer called myelodyplastic syndrome. It is typically treated with the drug decitabine. The researchers’ goal was to see if redesigning the regimen by which the drug is given would not only stop cancer cells from growing but also spare normal cells.
They recruited 25 people, whose average age was 73 to test their theory. Researchers lowered medication dosages, administered it by injection, and gave the injections more frequently.
‘Striking’ results
Results show this treatment method does have the potential to stop cancer cells from growing, while sparing normal cells. Dr. Saunthararajah stops short of calling it a cure, but he says it is a good first step towards safely and effectively treating cancers without causing damage to healthy cells.
“These results are so striking that I have no doubt that this is going to be an expanding area. It seems likely that we will see more cancers treated this way in the years to come,” Dr. Saunthararajah says.
Complete findings for the study titled: “Evaluation of non-cytotoxic dnmt1-depleting therapy in patients with myelodysplastic syndromes” are in the Journal of Clinical Investigation.